Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01156493 · ClinicalTrials.gov registry record · NA
Hydrolized Protein Formula for Premature Infants
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 137
- Enrollment target
NCT01156493 is a NA study that has completed, run by University of Miami. The registered enrollment target is 137 participants.
The verdict
NCT01156493, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
Study Summary
Premature infants fed with a protein hydrolyzed formula will have better tolerance needing shorter time to achieve full feeds when compared to those fed with an intact protein formula.
Interventions
- OTHER Protein Hydrolyzed Premature Formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2010-07 |
| Est. Completion | 2015-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01156493
The ClinicalTrials.gov registry entry for NCT01156493 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Protein Hydrolyzed Premature Formula is the first listed.
NCT01156493 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01156493 about?
NCT01156493 is a clinical study titled "Hydrolized Protein Formula for Premature Infants". Premature infants fed with a protein hydrolyzed formula will have better tolerance needing shorter time to achieve full feeds when compared to those fed with an intact protein formula.
What is the current status of trial NCT01156493?
This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2010-07. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01156493?
The interventions under investigation include: Protein Hydrolyzed Premature Formula (OTHER).
Who is sponsoring clinical trial NCT01156493?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.